A tiered subscription service providing equitable access to AI-discovered drugs. Higher tiers offer personalized dosage adjustments, real-time side-effect monitoring, and genetic testing to optimize drug efficacy and minimize adverse reactions to counteract unequal wealth distribution. Lower tiers offer subsidized or free access to essential medicines identified as high-impact for underserved communities.